Targeted Therapeutics Market Value Surpass USD 128 Billion by 2030

The global Targeted Therapeutics Market size is estimated to generate revenues of more than USD 128 billion by 2030, growing at a CAGR of around 2.4% from 2022 to 2030

The report covers SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. The report offers an analysis of the global targeted therapeutics Market for the period 2017 to 2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.

The wide application portfolio of targeted therapeutics market is one of factors driving the growth of market worldwide. The global market is moderately competitive with a blend of global and regional players. The markets key players invest significantly in R and D to enhance their offerings. The entire ecosystem is composed of multiple participants. Every participant of the ecosystem is an equal contributor to the growth of global market.

Why should you invest in this report?

If you are aiming to enter the global targeted therapeutics Market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for targeted therapeutics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly. Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Report Structure:

• pertinent market numbers of the global targeted therapeutics market along with the CAGR for the forecast period 2022-2030
• detailed definitions of different types of targeted therapeutics, which gives clarity about what this market is all about and also defines the scope of this report
• macroeconomic factors influencing the global targeted therapeutics market, along with market opportunity analysis
• key trends likely to impact the global targeted therapeutics market
• PESTLE analysis of all the regions as per the market taxonomy
• Porter’s Five Force Analysis of all the regions as given in the market taxonomy

Global market analysis and forecast:

• the global targeted therapeutics market analysis and forecast by product type, by application, by region and others
• key market metrics such as the BPS analysis, year-on-year growth rates, absolute dollar opportunity and market attractiveness analysis of the global targeted therapeutics market

Regional market analysis and forecast:

• Regional targeted therapeutics market analysis and forecast
• Regional market dynamics including the drivers, restraints and trends applicable across different regions in the targeted therapeutics market along with factors encouraging the growth of this market as well as the factors hampering the growth of this market
• Regional trends – both long term and short term

View Full Report@ https://www.precedenceresearch.com/targeted-therapeutics-market

Competitive landscape:

• the competitive landscape of this global report
• information on the various leading companies in the global market
• a dashboard view of the key companies operating in the global market along with their important information and broad strategy adopted to stay as leaders in the global market
• key company profiles along with important information such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis

Some of the prominent players in targeted therapeutics market include:

• Pfizer, Inc.
• AstraZeneca Plc.
• Amgen, Inc.
• F. Hoffmann-La Roche & Co.
• Genentech, Inc.
• Agenus, Inc.
• Celdara Medical LLC
• Arcus Biosciences, Inc.
• Aurinia Pharmaceuticals Inc.
• Gilead Sciences, Inc.
• Serena Therapeutics Inc.
• Nektar Therapeutics Inc.

Market Segmentation:

By Type

• Monoclonal Antibodies
• Small Molecule

By Application

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Renal Cancer
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of the World

Research Methodology

In this report, historical data, primary responses and public domain data has been thoroughly analyzed to infer the market size. Revenue of companies operating in the global market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to determine the market size for the forecast period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated using the triangulation method and extensively scrutinized using advanced tools to garner quantitative and qualitative insights into the global targeted therapeutics.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Targeted Therapeutics Market 

5.1. COVID-19 Landscape: Targeted Therapeutics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Targeted Therapeutics Market, By Type

8.1. Targeted Therapeutics Market, by Type, 2021-2030

8.1.1. Monoclonal Antibodies

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Small Molecule

8.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Targeted Therapeutics Market, By Application

9.1. Targeted Therapeutics Market, by Application, 2021-2030

9.1.1. Breast Cancer

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Colorectal Cancer

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Lung Cancer

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Renal Cancer

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Targeted Therapeutics Market, By Distribution Channel 

10.1. Targeted Therapeutics Market, by Distribution Channel, 2021-2030

10.1.1. Hospital Pharmacies

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Retail Pharmacies

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Online Pharmacies

10.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Targeted Therapeutics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2019-2030)

11.1.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2019-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2019-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2019-2030)

11.2.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2019-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2019-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2019-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2019-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2019-2030)

11.3.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2019-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2019-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2019-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2019-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2019-2030)

11.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2019-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2019-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2019-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.6.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2019-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.7.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2019-2030)

11.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2019-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.4.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2019-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.5.3. Market Revenue and Forecast, by Distribution Channel (2019-2030)

Chapter 12. Company Profiles

12.1. Pfizer, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. AstraZeneca Plc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Amgen, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. F. Hoffmann-La Roche & Co.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Genentech, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Agenus, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Celdara Medical LLC

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Arcus Biosciences, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Aurinia Pharmaceuticals Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Gilead Sciences, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Serena Therapeutics Inc.

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

12.12. Nektar Therapeutics Inc.

12.12.1. Company Overview

12.12.2. Product Offerings

12.12.3. Financial Performance

12.12.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms       

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333      

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: http://www.marketstatsnews.com/

Follow us on LinkedIn | Twitter | Facebook